Twist Bioscience Corporation (TWST) Profit Margins
Over the twelve months to 2026-06-30, Twist Bioscience Corporation (TWST) had gross margin 52.0%, operating margin -33.6%, net margin -31.7%, free cash flow margin -22.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TWSTTwist Bioscience CorporationFollow TWST — free
—
Price chart with a free account
- Market cap
- 8.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 13 Nov, in 20 days
| Line | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 12.8% | 31.8% | 39.1% | 41.4% | 36.6% | 42.6% | 50.7% | 52.0% | |
| Operating margin | -200.1% | -155.5% | -115.4% | -115.3% | -88.6% | -70.6% | -36.2% | -33.6% | |
| Net margin | -198.0% | -155.3% | -114.9% | -107.0% | -83.5% | -66.7% | -20.6% | -31.7% | |
| FCF margin | -188.8% | -168.8% | -105.3% | -111.1% | -69.5% | -22.1% | -20.1% | -22.7% |
USD millions · SEC XBRL
Twist Bioscience Corporation — questions
- What is Twist Bioscience Corporation's gross margin?
- 52.0% over the twelve months to 2026-06-30.
- What is Twist Bioscience Corporation's operating margin?
- -33.6% over the twelve months to 2026-06-30.
- What is Twist Bioscience Corporation's net profit margin?
- -31.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Twist Bioscience Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.